Delivery Order SPE2DB22D2006-SPE2DB25FV7XH

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,013.98 firm fixed-price delivery order is for the supply of 4567140961 - VENOFER 100 MG/5 ML VIAL 5ML, a medical product. The contract has a completion date of February 5, 2025 and does not have any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.74 firm fixed-price delivery order is for the provision of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,947.83 firm fixed price delivery order is for the supply of VENOFER 100 MG/5 ML VIAL 5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the...
This federal contract award, valued at $5,448.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a medical product, with an ultimate completion date of September 29, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a major pharmaceutical distribution company. The $7,203.58 firm fixed price contract is for the supply of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product, with a performance period ending on April 29, 2024. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a single-award Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,545.44 firm fixed-price delivery order is for the supply of Venofer 100 mg/5 ml vials, a critical medical product used in the treatment of iron deficiency anemia. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product. The award is a delivery order with a firm fixed price of $1,022.90 and an ultimate completion date of January 29, 2025. This contract award is not designated with a set-aside requirement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award, valued at $1,456.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Venofer 100 mg/5 ml vials, a pharmaceutical product, with a performance period ending on May 9, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,289.71 firm fixed-price delivery order is for the supply of Venofer 100 mg/5 ml vials, a medication used to treat iron deficiency anemia. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical company. The contract is for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product, with a firm fixed price of $3,150.06 and a completion date of February 5, 2024. This contract was not set aside for any particular business type. Amerisourcebergen Drug Corp is the prime contractor and has an...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV7XH
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,734.48 Firm Fixed Price delivery order is for VENOFER 200 MG/10 ML VIAL 10ML, a medical commodity supporting military healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract has no set-aside designation, indicating open competition.

Generated 5/4/25, 1:05 AM